The effects of di(2-ethylhexyl) phthalate (DEHP) on hepatic function and histology were evaluated in the rhesus monkey undergoing platelet and plasma transfusion. The average cumulative amount infused in one year is comparable to that received by patients who undergo chronic transfusion. Abnormalities in hepatic scan and BSP kinetics persisted for up to 26 months after transfusion, as did histologic abnormalities. Patients undergoing maintenance hemodialysis receive a yearly dose of DEHP which is 10-20 times that which produced hepatotoxicity in the transfused rhesus. the orosomucoid level which is slightly lower. In addition they behave similarly to both children and adults as far as compartmentalization analysis of bromosulfophthalein (BSP) kinetics and hepatic 99mTechnetium-labeled sulfur colloid scanning techniques.
The plasticizer di(2-ethylhexyl) phthalate (DEHP) is incorporated into poly(vinyl chloride) (PVC) medical devices to produce flexibility. PVC medical devices such as blood bags and indwelling intravenous catheters contain up to 40% by weight of DEHP. This material is leached from PVC by blood and lipoprotein-containing solutions (1) . This solubilization is time-and temperature-dependent (1) . Previous studies have demonstrated DEHP in the tissues of multitransfused patients and in neonates whose only exposure was indwelling umbilical catheters (2, 3). Jacobson and Kevy (4) have demonstrated that DEHP levels of 5 mg/dl, the concentration found in whole blood stored for 21 days at 4°C and in platelets stored at 22°C for 24 hr, significantly inhibits the growth of human diploid fibroblasts. As a consequence of this finding, rhesus monkeys were used in a chronic transfusion study in which PVC blood bags were compared with those made of polyethylene.
The the orosomucoid level which is slightly lower. In addition they behave similarly to both children and adults as far as compartmentalization analysis of bromosulfophthalein (BSP) kinetics and hepatic 99mTechnetium-labeled sulfur colloid scanning techniques.
These animals were transfused with either platelet-rich or platelet-poor plasma in a manner identical to that utilized in clinical medicine. This is an extremely critical point, because virtually all the toxicology literature relative to DEHP is based upon rodent exposure in a manner which in no way mimics the way the human is exposed via transfusion of blood products or renal dialysis.
Materials and Methods

Experimental Groups
Immature rhesus monkeys approximately six months old and weighing less than 5 
Preparation of Platelet-Rich Plasma
Adult donor monkeys were plasmapheresed biweekly to obtain platelet-rich plasma. Blood, 100 ml, was collected into a 150 ml PVC or polyethylene blood pack aseptically ifiled with 16 ml ACD anticoagulant. The blood was centrifuged in a SBV No. 1 International centrifuge at 500 g at room temperature for 10 min, and the platelet-rich plasma was aseptically transferred into a second 150 ml PVC or polyethylene transfer pack. These packs were then stored at 4 or 22°C for 48 hr. The average platelet count in each bag was 150,000/mm3. The red cells were returned to the donor monkeys.
Preparation of Plasma
Adult donor monkeys were plasmapheresed into PVC blood packs as detailed above, except that the whole blood was centrifuged at 2520 g for 10 min in a RC-3 Sorvall centrifuge. The plasma was transferred into a PVC transfer pack and stored at 22°C for up to 5 days. Each unit of plasma was tested and found to be platelet free.
DEHP Quantitation
Levels of DEHP in blood products, blood and tissue were determined by gas chromatography with the use of our modification of the method of Jaeger (4) . The sensitivity of the assay is 0.1 ppm (parts per million).
DEHP Dosage
The amount of DEHP received by an experimental animal was calculated as the number of milliliters of stored blood component received times its DEHP concentration. The total amount of DEHP was determined by a summation of the results of each transfusion.
KEVY AND JACOBSON
Hepatic Scintillation Scanning Techniques 9'9Technetium-labeled sulfur colloid provides stable count rates, is short-lived, and has favorable radiation dosimetry (5) . Each rhesus monkey received 99mTc at dose of 0.015 mCi/kg body weight. Within 45 min after injection, the abdomen was scanned. Peak counts were recorded over the substance of the liver and spleen for 3 min and repeated five times. The hepatosplenic ratio was then determined from the mean counts over the liver and the spleen.
Sulfobromophthalein (BSP) Transport
Sulfobromophthalein (BSP) transport was evaluated by the method of Quarfordt and associates (6) . Each study was performed after at least a 12-hr fast. BSP was injected intravenously in a dose of 5 mg/kg of body weight. Sequential blood samples were obtained from the arm opposite that used for injection. Zero time for the study was set at the midpoint of the injection, which took an average of 30 sec to complete. Blood samples were obtained prior to injection for BSP recovery studies, then at 3-min intervals for 30 min, and thereafter at 15-min intervals for up to 2 hr. After the final blood sample, urine was collected for BSP recovery.
The plasma disappearance curve following a single injection of BSP was analyzed by a computer technique for determining compartmental flow. The method computes the hepatic removal rate (HRR), hepatic to plasma reflux rate (H-PRR), the biliary secretory rate (BSR), and the urinary excretion rate (UER) by means of the simulation analysis and modeling technique of Berman and associates, with the use of the SAAM digital computer program on an IBM 370-5165 computer (7) . These rates are expressed as the fractional rate (i.e., percent transported) per minute.
The model was verified in the rhesus monkey by measurement of the disappearance of dye from the plasma and quantitation of the concentration of dye excreted in the bile and urine. The bile samples were obtained by cannulation of the common bile duct. The experimentally observed values were plotted along with the computer-calculated values and the curves were superimposed. An injected dose was established which would not saturate the transport processes. Data obtained by these methods were compared to previously reported studies by us (8) in normal children and adults and children with cystic fibrosis (CF).
Histopathology
Multiple surgical liver biopsies were performed on all transfused and nontransfused monkeys. In order to ensure adequate sampling for all studies, a wedge biopsy was obtained on each occasion. Tissues were rapidly fixed in formalin and embedded in paraffin. Sections were stained by hematoxylineosin, periodic acid-Schiff, periodic acid-Schiff-alcohol and Sudan Black. All preparations were examined in blinded fashion by four observers.
Results
DEHP Dosage
At the start of this study ten consecutive patients were identified who predictably would be multitransfused. During the course of one year, each unit of red cells, whole blood, plasma and platelets was quantitated for DEHP. Tissue Levels of DEHP One of the inherent difficulties of liver biopsies is that only small specimens can be obtained. Tissue samples obtained at biopsy averaged 225 mg wet weight (range 100-400 mg). The limit of sensitivity of our analysis for DEHP by G.C. is 0.1 ppm. Any samples with DEHP contents of 1.4 ppm to 1.5 ppm, levels well above background, were considered to have only a trace amount. Table 3 lists the DEHP content of liver tissue obtained both at biopsy and necropsy.
As shown in Table 3 , the initial biopsies of all the PVC transfused rhesus contained significant amounts of DEHP. The nontransfused and polyethylenetransfused monkeys had no detectable DEHP. The five month follow-up samples contained concentrations similar to those initially measured with the exception of one PRP-transfused monkey and the two plasma-transfused animals that only had trace amounts of DEHP. At the 14 month follow-up biopsy of the PRP animals, three had only trace amounts of DEHP, and one had no detectable level. Since these samples were in the lower range of the sensitivity of our assay for DEHP, we sacrificed one of the animals (rhesus "G"). The tissue samples utilized ranged from 2.5 to 4.0 g wet weight. Significant levels of DEHP were found in the liver, testis, heart and omental fat. The total residual organ level, excluding fat, was less than one percent of the dose administered.
DEHP was not detected in liver samples obtained at necropsy 32 months after transfusion, despite the persistence of abnormal histologic findings. Unfortunately, none of the samples were analyzed for the monoester (MEHP).
Hemodialysis Studies
Since the rate of leaching of DEHP from PVC is dependent on the temperature and lipid content of Samples of dialysate fluid were obtained from both the inflow and outflow sites during the indicated time intervals. The estimated amount of DEHP received by a patient was calculated from the concentration per milliliter of venous blood times the flow rate multiplied by the duration of dialysis.
As shown in Table 4 , DEHP was not demonstrated in the predialysis venous blood samples. All patients showed DEHP in the venous blood but none in the arterial blood during hemodialysis. The estimated total amount of DEHP delivered to each patient during a single dialysis varied from 32 mg to 90 mg. In one year the estimated total amount of DEHP received by a patient would range from 120 mg/kg to 335 mg/kg, a dose 10 to 20 times that which produced liver abnormalities in the rhesus monkey.
Intensive Plasma Exchange
Intensive plasma exchanges were performed with an IBM Blood Cell Separator, 5% albumin being used as replacement fluid. Blood flow rate varied between 50 and 80 cc/min. Blood samples were obtained before plasma exchange and at 30, 60, 90 min and at the conclusion of the exchange.
Three patients requiring maintenance plasma exchange were studied (Table 5 (5) . In mild forms of parenchy- 'ND = none detected. mal disease, not manifested by irregular distribution of tracer, changes can be quantitated by determining the relative distribution of radiocolloid between liver and spleen (9) .
Sulfobromophthalein metabolism and transport may be evaluated in several ways. The standard method determines the retention of BSP at a specific interval, usually 45 min after a single injection (10) . A more sensitive technique is the utilization of a two-compartmental model for the analysis of BSP kinetics. This was first described in the dog, subsequently validated in the human by Quarfordt et al. and in the rhesus monkey by ourselves. The observation that the normal BSP disappearance curve in the child and immature primate is a single exponential and only changes to a biexponential in the presence of liver disease or with age is of significance to the present study (8, 11) . At the time this study was completed, none of the rhesus had shed any of their deciduous teeth, nor had they reached sexual maturity. Their average weight was 4.54 kg. One of the monkeys who was part of the study to validate the BSP model had multiple determinations during a three-year period and converted from a single exponential to a biexponential. This occurred at approximately 5.5 years and at a weight of 10.45 kg. The biexponential curves noted in this study and those seen in children with mild liver disease differs from those produced by chronic injury in which the initial slope flattens due to the decrease in the hepatic removal rate (8) .
Even though the number of animals in each of the groups is too small for valid statistical analysis, a trend is observed in the PVC transfused monkeys. In the present study, prolonged abnormalities in hepatic scan and BSP kinetics occurred following DEHP infusion without changes in standard liver function tests. Six of seven animals had abnormal 99mTc scan ratios, and six of seven demonstrated abnormal BSP compartmental flow upon completion of transfusion therapy. These findings have persisted for up to 14 months following therapy in three of the four monkeys given PRP and one of the two monkeys transfused with plasma. Two the the three remaining monkeys given PRP continued to have abnormal 'Tc scan ratios 26 months following the cessation of transfusion therapy. The results of the serial liver biopsies in the PVC transfused monkeys were quite dramatic and all were abnormal except for the initial biopsy on rhesus "G" which was normal. Disturbances of hepatic architecture, the presence of round-cell infiltration, and multinucleated giant cells persisted throughout the follow-up period. The histologic abnormalities have been reported in apparently normal subhuman primates. Although none of the animals in this study had pretreatment biopsies, all seven PVC-transfused rhesus monkeys and none of the six control rhesus had abnormal histology. The probability of this being a chance occurrence is highly unlikely.
Although monkeys transfused with plasma stored in PVC received equivalent doses of DEHP to those in the PVC-PRP group, their duration of exposure was significantly shorter. This may account for the fact that histological changes in liver biopsy were milder and that their liver function as reflected in the kinetics of BSP transport returned to normal during the follow-up period.
The results of DEHP quantitation on the serial liver biopsies ofthe PVC transfused monkeys shows a decrease in the residual DEHP (12, 13) . This metabolite is a potent inhibitor of liver dehydrogenases, and theoretically may have greater potential for hepatotoxicity than the parent compound.
Based upon a comparison of the abnormalities observed in the platelet-rich plasma and plasma transfused rhesus, a larger dosage over a prolonged time period appears to be more toxic. This is clinically significant to patients undergoing hemodialysis who yearly are exposed to far greater amounts of DEHP than that which produced hepatic toxicity in the rhesus. These patients are more prone to liver disease which cannot be attributed to the hepatitis B surface antigen or non-A, non-B hepatitis.
PVC medical devices have a high degree of reliability and fabrication technology. While the histological and functional abnormalities induced by PVC plasticized with DEHP in the ranges used in this study are mild, they were produced at dose levels observed in transfusion therapy and at lower levels than those that are observed in hemodialysis.
